{"name":"Mahmoud I Mostafa","slug":"mahmoud-i-mostafa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Polymyxin e","genericName":"Polymyxin e","slug":"polymyxin-e","indication":"Serious infections caused by multidrug-resistant gram-negative bacteria (e.g., Pseudomonas aeruginosa, Acinetobacter baumannii)","status":"marketed"}]}],"pipeline":[{"name":"Polymyxin e","genericName":"Polymyxin e","slug":"polymyxin-e","phase":"marketed","mechanism":"Polymyxin E (colistin) disrupts bacterial cell membranes by binding to lipopolysaccharides and phospholipids, causing cell lysis and death.","indications":["Serious infections caused by multidrug-resistant gram-negative bacteria (e.g., Pseudomonas aeruginosa, Acinetobacter baumannii)","Cystic fibrosis-associated respiratory infections"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFBteEEtVkpMNVBEVUJmTXRLQXRnTmZJUkdZVkdsdk0wYTc5VTRqNklyN1MxZzdUVjFINlBMdC00OXMwemxHOUdjYWxiSUFzYk5fNlR6OTgxQTFPVGlKV0FUaVl6eTY5Zw?oc=5","date":"2025-11-11","type":"trial","source":"آراب فاينانس","summary":"Data Bank - آراب فاينانس","headline":"Data Bank - آراب فاينانس","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBPSUhteHUzbjQ1T3hEVzRLaGR0Vk5PXzAzZkd6VXplMDlCN1lhWF9kN08tZGFub1pycndWRzBaX0dBWnNVMzg2R0JfLWZQRlpOakNLTmhBc3g0YnVIWUtZ?oc=5","date":"2025-07-01","type":"pipeline","source":"Nature","summary":"based polyacrylonitrile polymer composites for removing pharmaceutical pollutants and heavy metals from wastewater - Nature","headline":"based polyacrylonitrile polymer composites for removing pharmaceutical pollutants and heavy metals from wastewater","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5RWS1sbUN4c2ZHRTJuSTl1N1Uya3hnSnZFek5tYV90bHBYUlNVWElxcHJfRHV5bHNtcFBwbnk0bGJpV0Z5SS1wM1JKcVBDUC1vYW5zMGJUcVpWMVg2aUU4?oc=5","date":"2022-07-28","type":"pipeline","source":"Nature","summary":"Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies | Scientific Reports - Nature","headline":"Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico ","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}